Show simple item record

dc.contributor.authorBanales, Jesus M.
dc.contributor.authorFeldstein, Ariel E.
dc.contributor.authorSanger, Hanna
dc.contributor.authorLukacs-Kornek, Veronika
dc.contributor.authorSzabo, Gyongyi
dc.contributor.authorKornek, Miroslaw
dc.date2022-08-11T08:09:52.000
dc.date.accessioned2022-08-23T16:46:41Z
dc.date.available2022-08-23T16:46:41Z
dc.date.issued2019-01-02
dc.date.submitted2019-03-12
dc.identifier.citation<p>Hepatol Commun. 2019 Jan 2;3(2):305-315. doi: 10.1002/hep4.1300. eCollection 2019 Feb. <a href="https://doi.org/10.1002/hep4.1300">Link to article on publisher's site</a></p>
dc.identifier.issn2471-254X (Linking)
dc.identifier.doi10.1002/hep4.1300
dc.identifier.pmid30766966
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40930
dc.description.abstractExtracellular vesicles (EVs) are small and heterogeneous membrane-bound structures released by cells and found in all biological fluids. They are effective intercellular communicators, acting on a number of close and/or distant target cells. EV cargo may reflect the cell of origin as well as the specific stress that induces their formation and release. They transport a variety of bioactive molecules, including messenger RNA, noncoding RNAs, proteins, lipids, and metabolites, that can be transferred among cells, regulating various cell responses. Alteration in the concentration and composition of EVs in biological fluids is a typical hallmark of pathologies in different liver diseases. Circulating EVs can serve as biomarkers or as messengers following uptake by other cells. This review is a meeting report from the International Liver Congress 2018 (European Association for the Study of the Liver) celebrated in Paris (Symposium: Extracellular vesicles and signal transmission) that discusses the role of EVs in several liver diseases, highlighting their potential value as disease biomarkers and therapeutic opportunities.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=30766966&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rights© 2018 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectextracellular vesicles
dc.subjectdisease biomarkers
dc.subjectliver diseases
dc.subjectDigestive System Diseases
dc.subjectGastroenterology
dc.subjectHepatology
dc.titleExtracellular Vesicles in Liver Diseases: Meeting Report from the International Liver Congress 2018
dc.typeJournal Article
dc.source.journaltitleHepatology communications
dc.source.volume3
dc.source.issue2
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=4743&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/3729
dc.identifier.contextkey14008325
refterms.dateFOA2022-08-23T16:46:41Z
html.description.abstract<p>Extracellular vesicles (EVs) are small and heterogeneous membrane-bound structures released by cells and found in all biological fluids. They are effective intercellular communicators, acting on a number of close and/or distant target cells. EV cargo may reflect the cell of origin as well as the specific stress that induces their formation and release. They transport a variety of bioactive molecules, including messenger RNA, noncoding RNAs, proteins, lipids, and metabolites, that can be transferred among cells, regulating various cell responses. Alteration in the concentration and composition of EVs in biological fluids is a typical hallmark of pathologies in different liver diseases. Circulating EVs can serve as biomarkers or as messengers following uptake by other cells. This review is a meeting report from the International Liver Congress 2018 (European Association for the Study of the Liver) celebrated in Paris (Symposium: Extracellular vesicles and signal transmission) that discusses the role of EVs in several liver diseases, highlighting their potential value as disease biomarkers and therapeutic opportunities.</p>
dc.identifier.submissionpathoapubs/3729
dc.contributor.departmentDepartment of Medicine, Division of Gastroenterology
dc.source.pages305-315


Files in this item

Thumbnail
Name:
Banales_et_al_2019_Hepatology_ ...
Size:
512.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© 2018 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Except where otherwise noted, this item's license is described as © 2018 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.